Quote | Mallinckrodt (OTCMKTS:MNKPF)
Last: | $17.25 |
---|---|
Change Percent: | 1.45% |
Open: | $17 |
Close: | $17.25 |
High: | $17.5 |
Low: | $15.26 |
Volume: | 1,437 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Mallinckrodt (OTCMKTS:MNKPF)
Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance PR Newswire Made Solid Progress on Launch of Terlivaz® with Significant Medical Community Interest Appointed Chief Scientific Officer with Proven Record of Executi...
Mallinckrodt to Present at Cowen's 43rd Annual Health Care Conference PR Newswire DUBLIN , Feb. 16, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that Siggi Olafsson , President ...
Message Board Posts | Mallinckrodt (OTCMKTS:MNKPF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Mallinckrodt Company Name:
MNKPF Stock Symbol:
OTCMKTS Market:
Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance PR Newswire Made Solid Progress on Launch of Terlivaz® with Significant Medical Community Interest Appointed Chief Scientific Officer with Proven Record of Executi...
Mallinckrodt to Present at Cowen's 43rd Annual Health Care Conference PR Newswire DUBLIN , Feb. 16, 2023 /PRNewswire/ -- Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that Siggi Olafsson , President ...
Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance PR Newswire Launched Terlivaz ® Following U.S. Food and Drug Administration (FDA) Approval in September; Submitted U.S. FDA Premarket Notification Application for Next-Generat...